gnb메뉴보기
ENG
Gnb 메뉴 닫기
Embrace Life
Global healthcare leader Celltrion will continue
its innovation to promote better and happier lives
for humanity
New Antibody for COVID-19
Check characteristics of Covid-19, an antiviral treatment mechanism of action, current status of the treatment development and the latest news.
Learn more
Biologics that are more approachable
Celltrion's antibody biosimilars provide patients
with high-quality yet affordable biopharmaceutical treatments
Pharmaceuticalsreinnovated
By venturing into the $833 billion global pharmaceutical market, we are excited to provide affordable healthcare for more patients around the world
Pioneering into the future
Celltrion has shifted the pharmaceutical paradigm with outstanding biopharmaceutical products, Research and Development capabilities, and expertise